FDA Approves CAR T-Cell Therapy for Leukemia – MedPage Today
MedPage Today |
FDA Approves CAR T-Cell Therapy for Leukemia
MedPage Today WASHINGTON — The FDA on Wednesday approved a chimeric antigen receptor (CAR) T-cell therapy for treatment of certain pediatric and young adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Calling it a "historic … First CAR T-Cell 'Living Drug' Approved by FDA FDA clears first gene-altering therapy — 'a living drug' — for childhood leukemia FDA Approves First Gene Therapy For Leukemia |
